Elevance Health (ELV) Share-based Compensation (2010 - 2026)

Elevance Health (ELV) has 17 years of Share-based Compensation data on file, last reported at $55.0 million in Q1 2026.

• Quarterly Share-based Compensation fell 32.1% year-over-year to $55.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $250.0 million (up 19.05% YoY) and the FY2025 annual result came in at $276.0 million, up 44.5% from the prior year.
• Share-based Compensation climbed to $55.0 million in Q1 2026 per ELV's latest filing, from $30.0 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $92.0 million in Q2 2024 and bottomed at -$29.0 million in Q4 2024.
• The 5-year median for Share-based Compensation is $72.0 million (2022), against an average of $63.2 million.
• The widest annual swing landed in 2024, when Share-based Compensation plunged 140.28%; it then surged 203.45% in 2025.
• Tracing ELV's Share-based Compensation over 5 years: stood at $73.0 million in 2022, then dropped by 1.37% to $72.0 million in 2023, then sank by 140.28% to -$29.0 million in 2024, then surged by 203.45% to $30.0 million in 2025, then surged by 83.33% to $55.0 million in 2026.
• Per Business Quant, the three latest ELV Share-based Compensation figures stand at $55.0 million (Q1 2026), $30.0 million (Q4 2025), and $84.0 million (Q3 2025).

Peer Comparison